company

APOTEKET I SON AS

1555 SON

Return on Equity
157,16 %
Current Ratio
0,92
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue33 473 000
Net Income1 350 000
Total Assets6 179 000
Total Equity859 000
Income (NOK)2022
Revenue33 473 000
Expenditure31 740 000
Operating Profit1 732 000
Financial Income1 000
Financial Costs1 000
Financial Balance0
Earnings Before Tax1 731 000
Tax382 000
Net Income1 350 000
Balance (NOK)2022
Total Fixed Assets1 272 000
Total Current Assets4 907 000
Total Assets6 179 000
Total Retained Equity759 000
Total Equity859 000
Total Long-Term Debt0
Total Current Debt5 320 000
Total Equity and Debt6 179 000
Cash flow (NOK)2022
Sales Income33 178 000
Other Income295 000
Revenue33 473 000
Cost of Goods Sold24 653 000
Salary Costs5 213 000
Depreciation90 000
Impairment0
Expenditure31 740 000
Operating Profit1 732 000
Financial Income1 000
Financial Costs1 000
Financial Balance0
Dividends600 000
Net Income1 350 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets18 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures194 000
Total Tangible Assets194 000
Total Fiancial Fixed Assets1 060 000
Total Fixed Assets1 272 000
Stock1 834 000
Total Investments0
Cash, Bank862 000
Total Current Assets4 907 000
Total Assets6 179 000
Total Equity859 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors3 292 000
Unpaid Taxes489 000
Dividends600 000
Other Current Debt555 000
Total Current Debt5 320 000
Total Equity and Debt6 179 000
Financial indicators2022
Return on Equity157,16 %
Debt-to-Equity Ratio0
Operating Profit Margin5,17 %
Current Ratio0,92
Quick Ratio1,41
Equity Ratio0,14
Gross Profit Margin26,35 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English